Physician profile
Deepa M Mathew
NPI 1619149325
$552.34
in general payments reported to CMS, 2019-2025
18 companies · $209 in 2025
The $209 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.12 · 2020: $19.66 · 2021: $49.34 · 2022: $63.62 · 2023: $109 · 2024: $38.64 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $105.11 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Cranial Technologies, INC | $69.46 | 2019-2025 | Doc Band |
| Ars Pharmaceuticals Operations, INC. | $49.09 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $38.27 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $37.84 | 2021 | |
| Sobi, INC | $28.09 | 2019 | |
| Pfizer INC. | $23.92 | 2025 | |
| Abbott Laboratories | $21.85 | 2025 | Freestyle Libre 3 |
| Kaleo, INC. | $21.62 | 2022 | |
| Corium, LLC | $20.64 | 2022 | |
| Amneal Pharmaceuticals LLC | $19.74 | 2019 | |
| Genentech USA, INC. | $19.66 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $18.48 | 2023 | Flumist Quadrivalent |
| Merck Sharp & Dohme LLC | $18.17 | 2025 | Vaxelis, Enflonsia, Vaxneuvance |
| Tris Pharma INC | $17.73 | 2025 | Dyanavel Xr |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $16.75 | 2023 | Grastek, Ragwitek, Odactra |
| Ironshore Pharmaceuticals INC. | $14.42 | 2023 | Jornay Pm |
| Cumberland Pharmaceuticals, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.